Use access key #2 to skip to page content.
$2.79 -0.07 (-2.45%)
7/3/2008 1:00 PM

MannKind Corp (MNKD)

CAPS Rating:
*

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View Ticker Page (MNKD)

Results 1 - 10 of 66 :   12345Next »

Recs

5

Avatar TheGarcipian (99.75) Submitted: 6/29/07 11:31 PM : Underperform Start Price: $12.33 MNKD Score: 61.09

A whole $10K in sales, eh? And debt already at 35% of equity? Hmmmm. Gonna be hard to make payroll. RoA=-46% and RoE=-108%? Wow. Do you guys have any good news? Oh yeah, I can SHORT you! Seriously, I really hope they can pull off better treatments fo...

Report this Post Replies: 1 | Reply | Permalink

Recs

4

Avatar csmith201 (99.12) Submitted: 6/14/07 4:15 PM : Outperform Start Price: $14.00 MNKD Score: -62.55

Predicting success for its inhaled insulin product... the Technosphere Insulin System, currently in late-stage clinical testing, should be on sale in the U.S. by 2010... the system delivers insulin in a way that mimics the body's release of the horm...

Report this Post Replies: 0 | Reply | Permalink

Recs

3

Avatar pa2818185 (< 20) Submitted: 8/30/06 9:46 PM : Outperform Start Price: $17.82 MNKD Score: -80.87

Superior inahled insulin device and forumulation making this a potential leader in the inhaled insulin market. Would be surprised to see the company bought by another large Pharma once the inhaled insulin market is established.

Report this Post Replies: 1 | Reply | Permalink

Recs

2

Avatar taxguydoug (61.81) Submitted: 6/06/07 2:50 PM : Outperform Start Price: $10.42 MNKD Score: -56.25

Bill Miller is bullish, that's enough for me.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar morningstarboy (< 20) Submitted: 12/05/07 12:49 PM : Outperform Start Price: $9.00 MNKD Score: -53.83

As of close of business on 12/04/2007, this was a 5-star Morningstar stock that was trading below half of it's Morningstar fair value.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar UncannyTiming (29.45) Submitted: 9/26/07 6:44 PM : Outperform Start Price: $9.48 MNKD Score: -53.17

Al Mann is The Man. He's made billions as a pioneer in this industry, and says this will be his biggest success yet. Technosphere's clinical testing is on schedule, and believe me, they're going to find a big partner. More than eight million Ameri...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar forbes10 (99.88) Submitted: 6/21/07 2:12 PM : Outperform Start Price: $12.96 MNKD Score: -61.66

Al Mann= Money in da bank

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar KahanaBob (85.01) Submitted: 6/20/07 4:24 PM : Outperform Start Price: $13.00 MNKD Score: -62.14

I am riding Bill Miller's coatails on this one based on his recommendation in the July Kiplinger article. There is a billion $ market if the inhalers are approved by FDA, and CEO Alfred Mann, is confident enough to have bought 5% of the outstanding...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Jonquille (< 20) Submitted: 6/17/07 2:44 PM : Outperform Start Price: $14.37 MNKD Score: -62.94

Insulin inhaler has huge market potential. Much better product than Exubera.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar AndyChip38 (< 20) Submitted: 6/26/07 12:33 AM : Outperform Start Price: $12.68 MNKD Score: -62.09

MNKD i believe is a solid company with a good purpose. Should climb once product becomes popular and safe.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners